← Eichor
Condition: Adrenocortical Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adrenocortical Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Collecting Information About Treatment Results for Patients With Cushing's Syndrome
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT03364803Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06487481A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resist
Phase 1 · 6 location(s) · Daiichi Sankyo · NCT07189403Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Phase N/A · 10 location(s) · Latin American Cooperative Oncology Group · NCT06279442An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143International Pediatric Adrenocortical Tumor Registry
Phase N/A · 5 location(s) · St. Jude Children's Research Hospital · NCT00700414Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · 60 location(s) · Sparrow Pharmaceuticals · NCT07296484PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05237934Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Phase 2 · 4 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT05563467Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Phase 2 · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT05913427Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc
Phase 3 · 33 location(s) · M.D. Anderson Cancer Center · NCT03583710Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisoli
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06246357Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adre
Phase 2 · 1 location(s) · West China Hospital · NCT04318730Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335679Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321Adrenal Tumors - Pathogenesis and Therapy
Phase N/A · 1 location(s) · University of Wuerzburg · NCT00669266National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
NA · 1 location(s) · Haukeland University Hospital · NCT05368090Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
NA · 1 location(s) · University Hospital, Toulouse · NCT07470580Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Phase 2 · 22 location(s) · UNICANCER · NCT06333314IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT07361874Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid
Phase 1 · 3 location(s) · Anusha Kalbasi · NCT04119024Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06066333Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Crinetics Pharmaceuticals Inc. · NCT05804669
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.